Galectin-3-ITGB1 信号传导介导乙型肝炎病毒转基因小鼠中肝脏常规自然杀伤细胞的白细胞介素 10 产生,并与患者的肝细胞癌进展相关。
Galectin-3-ITGB1 Signaling Mediates Interleukin 10 Production of Hepatic Conventional Natural Killer Cells in Hepatitis B Virus Transgenic Mice and Correlates with Hepatocellular Carcinoma Progression in Patients.
发表日期:2024 May 07
作者:
Yongyan Chen, Wendi Zhang, Min Cheng, Xiaolei Hao, Haiming Wei, Rui Sun, Zhigang Tian
来源:
BIOMEDICINE & PHARMACOTHERAPY
摘要:
乙型肝炎病毒感染的结果与复杂的免疫失衡有关;然而,HBV 引起免疫功能障碍的确切机制尚不清楚。HBV 转基因 (HBs-Tg) 小鼠被用来研究两个不同亚群的肝内 NK 细胞:常规 NK (cNK) 和肝驻留 NK (LrNK) 细胞在慢性 HBV 感染期间。cNK 细胞(而非 LrNK 细胞)是衰老 HBs-Tg 小鼠肝脏中大量 NK 细胞数量增加的主要原因。在衰老的 HBs-Tg 小鼠中,肝 cNK 细胞显示出更强的产生 IL-10 的能力,同时 CD69、TIGIT 和 PD-L1 的表达更高,而 NKG2D 的表达更低。与 HBs-Tg 小鼠的脾 cNK 细胞相比,在肝 cNK 细胞中观察到较低的线粒体质量和膜电位以及较少的极化定位。 HBsAg 肝细胞分泌的半乳糖凝集素 3 (Gal-3) 增强,通过 ITGB1 信号传导导致肝 cNK 细胞产生 IL-10。对于人类,LGALS3 和 ITGB1 表达与 IL-10 表达呈正相关,与 HCC 不良临床进展呈负相关。在慢性 HBV 感染期间,Gal-3-ITGB1 信号传导塑造肝脏 cNK 细胞,但不塑造 LrNK 细胞,这可能与随着 HCC 进展。
The outcomes of HBV infections are related to complex immune imbalances; however, the precise mechanisms by which HBV induces immune dysfunction are not well understood.HBV transgenic (HBs-Tg) mice were used to investigate intrahepatic NK cells in two distinct subsets: conventional NK (cNK) and liver-resident NK (LrNK) cells during a chronic HBV infection.The cNK cells, but not the LrNK cells, were primarily responsible for the increase in the number of bulk NK cells in the livers of ageing HBs-Tg mice. The hepatic cNK cells showed a stronger ability to produce IL-10, coupled with a higher expression of CD69, TIGIT and PD-L1, and lower NKG2D expression in ageing HBs-Tg mice. A lower mitochondrial mass and membrane potential, and less polarized localization were observed in the hepatic cNK cells compared with the splenic cNK cells in the HBs-Tg mice. The enhanced galectin-3 (Gal-3) secreted from HBsAg+ hepatocytes accounted for the IL-10 production of hepatic cNK cells via ITGB1 signaling. For humans, LGALS3 and ITGB1 expression is positively correlated with IL-10 expression, and negatively correlated with the poor clinical progression of HCC.Gal-3-ITGB1 signaling shapes hepatic cNK cells but not LrNK cells during a chronic HBV infection, which may correlate with HCC progression.